bibliographicCitation |
Lu J, Zhou K, Yin X, Xu H, Ma B. Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer. Computational Biology and Chemistry. 2019 Feb;78():290–6. doi: 10.1016/j.compbiolchem.2018.12.007. |